nbc news semaglutide Weight loss drug shortages prompt pharmacies to make similar medications Is compounded weight loss drug

Readers should rely on the official Omzo website at omzo.com and on FDA.gov as the authoritative sources for current product and regulatory information prior to any purchase decision

and B.J

Curr Opin Nephrol Hypertens (2009) 18(5):41220

It's an investigational drug in Phase 3 clinical trials Expected availability: 2027-2028 after FDA approval, assuming Phase 3 trials complete successfully Current access options: Clinical trial enrollment (free), compounding pharmacies with prescription ($200-500/month), or research peptides ($150-500/month) By country: Not approved in US, UK, EU, Australia, or Canada

1 in 3 for women), according to the International Osteoporosis Foundation

They are not intended for human or veterinary use, and purchasing them constitutes an agreement to use them solely for contained lab work